Barroso E.
78
Coauthors
7
Documentos
Volumen de publicaciones por año
Cargando gráfico
| Año de publicación | Num. Publicaciones |
|---|---|
| 2007 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2019 | 1 |
| 2021 | 1 |
Publicaciones por áreas de conocimiento
Cargando gráfico
| Área de conocimiento | Num. Publicaciones |
|---|---|
| Neurología | 3 |
| Neuropsicología | 2 |
| Enfermedad cardiovascular | 2 |
| Bioquímica | 2 |
| Toxicología | 2 |
| Farmacología | 1 |
| Nanopartícula | 1 |
| Fisiología | 1 |
| Biología molecular | 1 |
Publicaciones por áreas temáticas
Cargando gráfico
| Área temática | Num. Publicaciones |
|---|---|
| Enfermedades | 5 |
| Farmacología y terapéutica | 4 |
| Fisiología humana | 4 |
| Medicina y salud | 1 |
| Salud y seguridad personal | 1 |
| Fisiología y materias afines | 1 |
| Otros problemas y servicios sociales | 1 |
| Bioquímica | 1 |
| Microorganismos, hongos y algas | 1 |
Principales fuentes de datos
| Origen | Num. Publicaciones |
|---|---|
| Scopus | 7 |
| Google Scholar | 0 |
| RRAAE | 0 |
Cargando gráfico
Coautores destacados por número de publicaciones
| Coautor | Num. Publicaciones |
|---|---|
| Antoni Camins | 7 |
| Vázquez-Carrera M. | 6 |
| Pallás M. | 5 |
| Folch J. | 3 |
| Palomer X. | 3 |
| Espina M. | 2 |
| Souto E.M.B. | 2 |
| Cano A. | 2 |
| García M.L. | 2 |
| Ettcheto M. | 2 |
Cargando gráfico
Top Keywords
Cargando gráfico
Publicaciones del autor
Resveratrol induces nuclear factor-κB activity in human cardiac cells
ArticleAbstract: Background: Resveratrol is a grape polyphenol that prevents cardiac hypertrophy and protects the heaPalabras claves:Cardiovascular disease, heart, inflammation, NF-κB, Resveratrol, STAT3Autores:Álvarez-Guardia D., Antoni Camins, Barroso E., Capdevila-Busquets E., Davidson M.M., Pallás M., Palomer X., Planavila A., Vázquez-Carrera M., Villarroya F.Fuentes:scopusState of the art on toxicological mechanisms of metal and metal oxide nanoparticles and strategies to reduce toxicological risks
ReviewAbstract: Metal nanoparticles have been extensively investigated for different types of pharmaceutical applicaPalabras claves:Metal nanoparticles, Nanoparticles functionalization, Nanoparticles toxicity, Reactive oxygen speciesAutores:Antoni Camins, Barroso E., Cano A., Espina M., Ettcheto M., García M.L., García-Torra V., Sanchez-Lopez E., Souto E.M.B., Vázquez-Carrera M.Fuentes:scopusEarly alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's disease
ArticleAbstract: The present study had focused on the behavioral phenotype and gene expression profile of molecules rPalabras claves:Alzheimer's disease, APPswe/PS1dE9, hippocampus, insulin receptor, Mitochondria, TauAutores:Allgaier M., Antoni Camins, Auladell C., Barroso E., Casadesús G., Folch J., Pallás M., Pedros I., Petrov D., Sureda F.X., Vázquez-Carrera M., Zárate C.B.Fuentes:scopusPeroxisome proliferator-activated receptor α down-regulation is associated with enhanced ceramide levels in age-associated cardiac hypertrophy
ArticleAbstract: We used an experimental murine model of accelerated aging, the senescence-accelerated mouse (SAM), tPalabras claves:Autores:Alegret M., Antoni Camins, Barroso E., Coll T., Laguna J.C., Merlos M., Pallás M., Palomer X., Rodríguez-Calvo R., Sánchez R.M., Serrano L., Vázquez-Carrera M.Fuentes:scopusDual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model
ArticleAbstract: Epigallocatechin-3-gallate (EGCG) is a candidate for treatment of Alzheimer's disease (AD) but its iPalabras claves:Alzheimer's disease, APP/PS1 mice, EGCG, Epigallocatechin gallate, PLGA-PEG, Polymeric nanoparticlesAutores:Antoni Camins, Auladell C., Barenys M., Barroso E., Cano A., Chang J.H., Espina M., Ettcheto M., Folch J., García M.L., Kühne B.A., Souto E.M.B., Turowski P.Fuentes:scopus